|
- Interstitial Lung Diseases - Causes and Risk Factors | NHLBI, NIH
Learn about the causes and risk factors of interstitial lung diseases, which cause scarring in your lungs
- Interstitial lung disease - Symptoms and causes - Mayo Clinic
Interstitial (in-tur-STISH-ul) lung disease, also called ILD, describes a large group of conditions Most of these conditions cause inflammation and progressive scarring of lung tissue
- Interstitial Lung Disease (ILD) - American Lung Association
Many things can increase the risk of or cause ILDs including genetics, certain medications or medical treatments such as radiation or chemotherapy Exposure to hazardous materials has been linked to ILDs such as asbestosis and hypersensitivity pneumonitis
- Causes and Risk Factors of Interstitial Lung Disease
Interstitial lung disease (ILD) is an umbrella term used for a large group of diseases that cause scarring (fibrosis) of the lungs It affects millions of people globally
- ILD | Pulmonology Critical Care | Loyola Medicine
Interstitial lung disease (ILD) is a broad term for a group of over 200 chronic lung disorders that cause inflammation and scarring of the lungs (fibrosis) These diseases all affect the tissue that surrounds the lung’s air sacs, blood vessels, and airways called the interstitium
- Interstitial Lung Disease - Brigham and Womens Hospital
Interstitial Lung Disease (ILD), also referred to as pulmonary fibrosis or interstitial pneumonia, comprises a group of conditions characterized by inflammation and scarring around the tiny air sacs (alveoli) in the lungs
- Understanding Interstitial Lung Disease and Pulmonary Fibrosis: Causes . . .
Genetics: Family history of lung disease can increase the risk of developing ILD or PF Autoimmune Disorders: Diseases such as rheumatoid arthritis, scleroderma, and lupus can lead to ILD and PF
- Progressive Fibrosing Interstitial Lung Disease Primer
Table 1:PF-ILD population indices and risk factors for progressive disease Table 2:PF-ILD progression and mortality Table 3:Clinical, radiologic, and histologic features of common PF-ILD subtypes Table 4:Immunosuppressive therapies for PF-ILD Table 5:Antifibrotic therapies tested in for PF-ILD 6MWD:6 minute walk distance
|
|
|